Results 171 to 180 of about 151,004 (296)

Integrating NMR and contact-response analysis reveals the allosteric network driving domain closure in Enzyme I. [PDF]

open access: yesProc Natl Acad Sci U S A
Singh A   +5 more
europepmc   +1 more source

Synthesis of novel allosteric modulators of the G-protein coupled receptor CB1

open access: yes, 2015
CB1 allosteric modulators provide new opportunities to specifically regulate biological responses mediated by CB1 receptor. This approach is an attempt to infer information about the mode of binding interactions and signaling efficacy produced by ...
Samala, Sushma
core  

Explainable AI reveals the allosteric blind spot in protein-ligand binding predictions. [PDF]

open access: yesCell Rep Phys Sci
Parikh V   +5 more
europepmc   +1 more source

MDL‐800‐induced SIRT6 activation decreases age‐associated osteoarthritis in mice

open access: yesArthritis &Rheumatology, Accepted Article.
Objective SIRT6 is a nuclear‐localized histone deacetylase that regulates multiple pathways associated with aging. This study aimed to determine whether systemic administration of a small molecule activator of SIRT6, MDL‐800, decreases the severity of age‐associated osteoarthritis (OA) in mice.
Matheus Moreira Perez   +13 more
wiley   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy